Cargando…
CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients
Introduction: Bone metastasis is one of the causes that mainly decrease survival in patients with advanced breast cancer. Therefore, it is essential to find prognostic markers for the occurrence of this type of metastasis during the early stage of the disease. Currently, cancer-associated fibroblast...
Autores principales: | Giorello, María Belén, Martinez, Leandro Marcelo, Borzone, Francisco Raúl, Padin, María del Rosario, Mora, María Florencia, Sevic, Ina, Alaniz, Laura, Calcagno, María de Luján, García-Rivello, Hernán, Wernicke, Alejandra, Labovsky, Vivian, Chasseing, Norma Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501720/ https://www.ncbi.nlm.nih.gov/pubmed/37719885 http://dx.doi.org/10.3389/fcell.2023.1250869 |
Ejemplares similares
-
CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
por: Martinez, Leandro Marcelo, et al.
Publicado: (2015) -
Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer
por: Labovsky, Vivian, et al.
Publicado: (2017) -
Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy
por: Sanmartin, María Cecilia, et al.
Publicado: (2022) -
Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients
por: BORZONE, FRANCISCO RAÚL, et al.
Publicado: (2023) -
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023)